Clinical Trial: Study of YKST02 Alone or in Combination With YK012 in Patients With Active or Refractory Systemic Lupus Erythematosus

U.S., April 7 -- ClinicalTrials.gov registry received information related to the study (NCT07512947) titled 'Study of YKST02 Alone or in Combination With YK012 in Patients With Active or Refractory Systemic Lupus Erythematosus' on March 27.

Brief Summary: The purpose of this clinical trial is to evaluate the safety, tolerability, pharmacokinetics (PK), pharmacodynamics (PD), immunogenicity, and preliminary efficacy of YKST02 administered alone or in combination with YK012 in participants with active or refractory systemic lupus erythematosus (SLE).

The main questions this study aims to address are:

* Whether YKST02 alone or in combination with YK012 is safe and well tolerated in participants with active or refractory SLE

* Whether YKST0...